Gong Mengchun, M.D., graduated from the eight-year clinical medicine program of Peking Union Medical College. He participated in the establishment of the National Rare Disease Registration System (NRDRS, www.nrdrs.org) in China and served as its executive director until 2019. Currently, he is a partner of Digital Health China Technologies Co., Ltd., serving as the Senior Vice President and Chief Medical Officer. He is also the director of Guangdong Medical University Multimodality Data Innovation Lab (GMC Lab), a visiting professor at the Global Health Institute of Xi’an Jiaotong University, and the PI of the National Clinical Medical Center for Geriatric Diseases of Huashan Hospital affiliated to Fudan University.

His main research areas include medical informatics, phenomics, health technology assessment, research on health policies related to rare diseases, and medical education. He has published more than 40 academic papers in internationally renowned journals such as Lancet Regional Health WP, JMIR, eBioMedicine, Drug Safety, etc., as the first author or corresponding author. The paper Cloud-Based System for Effective Surveillance and Control of COVID-19: Useful Experiences From Hubei, China, published in JMIR in April 2020, was selected as the Best Paper of the Year by the International Medical Informatics Association (IMIA), and the relevant achievements won the WHO Innovation Award in 2021. He serves as a director of the SNOMED International Global Management Committee and a member of the Diagnostic Science Committee of the International Rare Diseases Research Consortium (IRDiRC). He is also a member of the Standing Committee of Bioinformatics Branch of the Chinese Preventive Medicine Association, the Standing Committee of the Chinese Bioinformatics Society, and the Big Data and Real-World Research Committee and the Artificial Intelligence Committee of the Chinese Anti-Cancer Association (CACA).

文章发表（部分）
Gong M, Jiao Y, Gong Y, Liu L. Data standards and standardization: The shortest plank of bucket for the COVID-19 containment. Lancet Reg Health West Pac. 2022 Aug 11:100565. doi: 10.1016/j.lanwpc.2022.100565. Epub ahead of print.

Gong M, Yu Y, Ouyang Z, Shi W, Liu C, Wang Q, Nan J, Cai E, Ding F, Nie S. Privacy protection of sexually transmitted infections information from Chinese electronic medical records. Sci Rep. 2025 Jan 8;15(1):1296. doi: 10.1038/s41598-024-84658-9.

Liu C, Jiao Y, Su L, Liu W, Zhang H, Nie S, Gong M. Effective Privacy Protection Strategies for Pregnancy and Gestation Information From Electronic Medical Records: Retrospective Study in a National Health Care Data Network in China. J Med Internet Res. 2024 Aug 20;26:e46455. doi: 10.2196/46455.

Liang L, Hu J, Sun G, Hong N, Wu G, He Y, Li Y, Hao T, Liu L, Gong M. Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources. Drug Saf. 2022 May;45(5):511-519.
Gong M, Liu L, Sun X, Yang Y, Wang S, Zhu H. Cloud-Based System for Effective Surveillance and Control of COVID-19: Useful Experiences From Hubei, China. J Med Internet Res. 2020;22(4):e18948.

Gong M, Wang S, Wang L, et al. Evaluation of Privacy Risks of Patients' Data in China: Case Study. JMIR Med Inform. 2020;8(2):e13046. Published 2020 Feb 5. doi:10.2196/13046

Wang HR, Gong M, Sun JY, Sun J, Guo Y, Liu L, Zhu H. A new model for COVID-19 control and its implementation in the city of Honghu, China: a case report. Antimicrob Resist Infect Control. 2021 Feb 25;10(1):42.

Dany Lützel serves as the General Manager of the Art & Boutique Hotel Éclat Beijing since 2017. Dany – a Swiss native – was the Pre-Opening General Manager for Niccolo Hotel in Chongqing. He ommenced his China journey in 2013 with Kempinski Chongqing, where he began as Resident Manager and quickly moved up to the top role in 2015. Previously, he was also General Manager of Radisson Blu, St. Gallen in Switzerland, a property where Dany spent over seven years. Back in St. Gallen, Switzerland, he was President of the St. Gallen Hoteliers Association, Member of the Board of St. Gallen Bodensee Tourism and a Member of SKAL.

With experience in Europe, the Middle East and China, Dany possesses the knowledge to drive revenues from both the domestic and international markets while maintaining a consistently high service level. Under his leadership, Éclat Hotel ranked on TripAdvisor as one of the top 3 Hotels in China and enjoys an excellent reputation in the national and overseas markets as a top high-end luxury Art & Boutique Hotel. His ability to effectively manage small and medium-sized operations allows him to deliver bespoke and personalized service. In 2023, Conde Nast Traveler Readers Choice Award ranked the Hotel as the No. 1 Hotel in China and as the 37 best Hotels worldwide, and in 2024 Conde Nast Traveler Readers Choice Awards No.9 Hotel in China.

Dany holds a management degree in hospitality from the hotel management school in Lucerne, Switzerland, as well as an Executive Master in Business Administration (E-MBA). He is married with two children and speaks fluent English, German and French. In Beijing, he chairs the Swiss Club as President and is a Member of the Board of the internationally renowned and acclaimed gastronomic society La Confrérie de la Chaîne des Rôtisseurs, which was founded in Paris in 1950.

He serves as a member of the International Advisory Board of Hoteliers (“IABH”) of Small Luxury Hotels of the World Holdings LLP (the "LLP" or "SLH LLP") and has established over his previous term excellent relationship with the existing Small Luxury Hotels in his region.

Robert Xiao is the Director of the Economist Intelligence Corporate Network (EICN) in Beijing. He is responsible for engaging with top executives in the region and providing insights on economic and policy trends to support their business development in the Chinese market.

Mr Xiao was previously a PhD Supervisor and Deputy Director of the Impact Finance Hub at Deakin Business School before joining EICN. His research mainly focused on the fields of corporate social responsibility, corporate governance, and economic and financial policy analysis related to the Chinese market. He has authored multiple publications in Financial Times Top 50 Journals and been awarded major research grants jointly by the Australia Academy of Social Sciences and Chinese Academy of Social Sciences. He also has more than a decade of experience teaching business courses including in Master of Business Administration (MBA), Master of Finance, and Bachelor of Commerce programmes at leading universities.

Mr Xiao has a Ph.D. in Finance and B.Com. (Hons) in Accounting and Finance from Monash University.